---
figid: PMC2917385__nihms200259f1
figlink: /pmc/articles/PMC2917385/figure/F1/
number: F1
caption: Epidermal growth factor receptor (EGFR) activation, which often occurs in
  NSCLC, leads to upregulation of the PI3K/Akt pathway as well as the Raf/MEK/ERk
  kinase pathway. Akt pathway activation has been implicated in both resistance of
  cells to radiation-induced killing and in increased expression of hypoxia-inducible
  factor-1 (HIF-1) and vascular endothelial growth factor (VEGF). A number of drugs
  that can inhibit various points along these pathways have been shown in pre-clinical
  models to increase the radiation responsiveness of tumors.
pmcid: PMC2917385
papertitle: The Tumor Microenvironment in Non-Small Cell Lung Cancer.
reftext: Edward E. Graves, et al. Semin Radiat Oncol. ;20(3):156-163.
pmc_ranked_result_index: '71755'
pathway_score: 0.9550595
filename: nihms200259f1.jpg
figtitle: Tumor Microenvironment in Non-Small Cell Lung Cancer
year: ''
organisms: Homo sapiens
ndex: b125733c-dee5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2917385__nihms200259f1.html
  '@type': Dataset
  description: Epidermal growth factor receptor (EGFR) activation, which often occurs
    in NSCLC, leads to upregulation of the PI3K/Akt pathway as well as the Raf/MEK/ERk
    kinase pathway. Akt pathway activation has been implicated in both resistance
    of cells to radiation-induced killing and in increased expression of hypoxia-inducible
    factor-1 (HIF-1) and vascular endothelial growth factor (VEGF). A number of drugs
    that can inhibit various points along these pathways have been shown in pre-clinical
    models to increase the radiation responsiveness of tumors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - EGFR
  - NRAS
  - VEGFD
  - AKT1
  - HIF1A
  - ARAF
  - KRAS
  - PTEN
  - PIK3CD
  - PIK3R3
  - PGF
  - AKT3
  - MTOR
  - HRAS
  - RAF1
  - BRAF
  - VEGFC
  - PIK3R6
  - MAP2K1
  - MAP2K2
  - MAPK3
  - PIK3CB
  - PIK3CG
  - RBMS1
  - VEGFA
  - VEGFB
  - PIK3R5
  - MAPK1
  - PIK3CA
  - PIK3R4
  - LY294002
  - nelfinavir
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: YC1
  symbol: YC1
  source: hgnc_alias_symbol
  hgnc_symbol: RBMS1
  entrez: '5937'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: (PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: LY294002
  source: MESH
  identifier: C085911
- word: nelfinavir
  source: MESH
  identifier: D019888
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2917385__F1
redirect_from: /figures/PMC2917385__F1
figtype: Figure
---
